Abdi Ibrahim Remede Pharma has its own raw material production base, where the production management team has decades of experience in plant production
Lipid Nanoparticles (LNPs) are delivery systems commonly employed in the field of nucleic acid drugs. The LNPs in mRNA COVID-19 vaccines cons…
Abdi Ibrahim Remede Pharma stands at the forefront of the global market as a premier supplier of PEG derivatives and a Contract Development and Manufacturing Organization (CDMO) for Active Pharmaceutical Ingredients (APIs) and intermediates. From research and development to full-scale commercial production, we offer unparalleled support throughout the product lifecycle. Our advanced PEGylation technology delivers critical solutions to the biopharmaceutical sector. In addition, we provide customized raw material solutions to the chemical pharmaceutical industry, leveraging cutting-edge CDMO capabilities. Currently, Abdi Ibrahim Remede Pharma is powered by a dedicated workforce of over 500 professionals and hosts a robust and adept R&D team, which includes more than 10 experts recognized at national, provincial, and municipal levels.
ABOUT US
Professional Services
Abdi Ibrahim Remede Pharma has accumulated a large amount of professional knowledge and experience in process research and development. In order to better serve customers, we have built a CDMO technology platform, equipped with professional R&D, production and QC teams, established a pilot and scale-up production workshop that meets GMP standards
Abdi Ibrahim Remede Pharma is a dedicated and experienced customer support group that can help you identify the right PEG derivatives for your PEGylation needs.
Abdi Ibrahim Remede Pharma provides reliable custom chemical synthesis services. We have a first-class R&D team, led by a Ph.D. with decades of organic synthesis experience, and an international R&D team of doctors and masters to provide customers with comprehensive chemical customization services.